World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
50697
World Ranking
12425
National Ranking
6361

Jerry P. Palmer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jerry P. Palmer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 319 publications — 21st percentile

21% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jerry P. Palmer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jerry P. Palmer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Jerry P. Palmer is affiliated with the University of Washington in the United States and has contributed extensively to research in the fields of medicine, biochemistry, genetics, and molecular biology. Their work predominantly focuses on endocrinology, diabetes, and metabolism, with significant attention given to pancreatic function and diabetes management.

The main topics covered in their research output include:

  • Pancreatic function and diabetes
  • Diabetes Management and Research
  • Diabetes and associated disorders
  • Diabetes Treatment and Management
  • Metabolism, Diabetes, and Cancer
  • Immune Cell Function and Interaction
  • Blood Pressure and Hypertension Studies

Jerry P. Palmer's frequent co-authors reflect collaborations with established researchers in the field, including:

  • Steven E. Kahn
  • Kieren J. Mather
  • Kristina M. Utzschneider
  • Kristen J. Nadeau
  • Jay M. Sosenko

The scholar has published primarily in venues that focus on diabetes and metabolic research. Most publications appear in:

  • Diabetes Care
  • Diabetes
  • Diabetologia
  • Journal of Clinical Investigation
  • Endocrine Reviews

Among recent papers authored or co-authored by Jerry P. Palmer are:

  • Residual β cell function in long-term type 1 diabetes associates with reduced incidence of hypoglycemia, 2021, Journal of Clinical Investigation
  • Advances in Type 1 Diabetes Prediction Using Islet Autoantibodies: Beyond a Simple Count, 2021, Endocrine Reviews
  • Baseline Predictors of Glycemic Worsening in Youth and Adults With Impaired Glucose Tolerance or Recently Diagnosed Type 2 Diabetes in the Restoring Insulin Secretion (RISE) Study, 2021, Diabetes Care
  • OGTT Glucose Response Curves, Insulin Sensitivity, and β-Cell Function in RISE: Comparison Between Youth and Adults at Randomization and in Response to Interventions to Preserve β-Cell Function, 2021, Diabetes Care
  • Differential loss of β-cell function in youth vs. adults following treatment withdrawal in the Restoring Insulin Secretion (RISE) study, 2021, Diabetes Research and Clinical Practice

The research primarily addresses key issues in diabetes pathophysiology, including pancreatic β-cell function, glycemic control, and factors influencing disease progression in both youth and adults.

Jerry P. Palmer has also contributed to knowledge on the genetic and molecular basis of diabetes, synthesizing insights into immune cell function and the complex interactions influencing metabolic health.

Their body of work has emphasized multiple subfields within medicine such as surgery, genetics, and immunology, reflecting a comprehensive approach to diabetes and metabolic disorders research.

Best Publications

  • Report of the expert committee on the diagnosis and classification of diabetes mellitus

    James R. Gavin;K. G M M Alberti;Mayer B. Davidson;Ralph A. DeFronzo

  • Follow-up report on the diagnosis of diabetes mellitus.

    Saul Genuth;K. G M M Alberti;Peter Bennett;John Buse

  • Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

    S E Kahn;R L Prigeon;D K McCulloch;E J Boyko

  • Insulin antibodies in insulin-dependent diabetics before insulin treatment

    Jerry P. Palmer;Christopher M. Asplin;Peter Clemons;Kenneth Lyen

  • Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis

    Jay S. Skyler;George L. Bakris;Ezio Bonifacio;Tamara Darsow

  • Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

    Skyler Js;Krischer Jp;Wolfsdorf J;Cowie C

  • Somatostatin: Hypothalamic Inhibitor of the Endocrine Pancreas

    Donna J. Koerker;Willy Ruch;Elliott Chideckel;Jerry Palmer

  • C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function: Report of an ADA Workshop, 21–22 October 2001

    Jerry P. Palmer;G. Alexander Fleming;Carla J. Greenbaum;Kevan C. Herold

  • Latent autoimmune diabetes in adults (LADA) should be less latent.

    S Fourlanos;F Dotta;C J Greenbaum;J P Palmer

  • Aspirin Effects on Mortality and Morbidity in Patients With Diabetes Mellitus: Early Treatment Diabetic Retinopathy Study Report 14

    Aaron Kassoff;Sheldon M. Buzney;J. Wallace McMeel;John J. Weiter

  • Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the diabetes control and complications trial

    Neil H. White;Wanjie Sun;Patricia A. Cleary;Ronald P. Danis

  • Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial

    Diane K Wherrett;Brian Bundy;Dorothy J Becker;Linda A DiMeglio

  • GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus

    Johnny Ludvigsson;David Krisky;Rosaura Casas;Tadej Battelino

  • Insulin, glucagon, and glucose exhibit synchronous, sustained oscillations in fasting monkeys

    Charles J. Goodner;Barbara C. Walike;Donna J. Koerker;John W. Ensinck

  • Glutamate decarboxylase-, insulin-, and islet cell-antibodies and HLA typing to detect diabetes in a general population-based study of Swedish children.

    William A. Hagopian;Carani B. Sanjeevi;Ingrid Kockum;Mona Landin-Olsson

  • Fall in C-peptide during first 2 years from diagnosis: Evidence of at least two distinct phases from composite type 1 diabetes TrialNet data

    C. J. Greenbaum;C. A. Beam;D. Boulware;S. E. Gitelman

  • Pancreatic Islet Autoantibodies as Predictors of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1

    Tihamer Orban;Jay M. Sosenko;David Cuthbertson;Jeffrey P. Krischer

  • A novel micro-assay for insulin autoantibodies.

    Alistair J.K. Williams;Polly J. Bingley;Ezio Bonifacio;Jerry P. Palmer

  • Genetic Effects on Age-Dependent Onset and Islet Cell Autoantibody Markers in Type 1 Diabetes

    Jinko Graham;William A. Hagopian;Ingrid Kockum;Lou Sheng Li

  • Arginine-stimulated acute phase of insulin and glucagon secretion in diabetic subjects.

    J P Palmer;J W Benson;R M Walter;J W Ensinck

Frequent Co-Authors

Jay S. Skyler
Jay S. Skyler University of Miami
Carla J. Greenbaum
Carla J. Greenbaum Virginia Mason Medical Center
Jeffrey P. Krischer
Jeffrey P. Krischer University of South Florida
Kevan C. Herold
Kevan C. Herold Yale University
Åke Lernmark
Åke Lernmark Lund University
John M. Lachin
John M. Lachin George Washington University
Dorothy J. Becker
Dorothy J. Becker University of Pittsburgh
Desmond A. Schatz
Desmond A. Schatz University of Florida
Steven E. Kahn
Steven E. Kahn University of Washington
George S. Eisenbarth
George S. Eisenbarth University of Colorado Denver

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine but seeking alternative or complementary educational options, several online degrees and career pathways are available. These programs can help launch or advance careers in healthcare beyond the traditional MD or DO route.

Many professionals pursue cheap online dnp programs, which offer flexibility and affordability for nurses aiming for leadership or advanced practice roles. Similarly, pharmacists can enhance their education with pharm d online programs, often designed to accommodate working professionals.

For those interested in health technology, a degree in health informatics opens doors to careers in managing digital health records and health data security. Meanwhile, students looking for entry-level healthcare roles can consider affordable medical billing and coding programs that are quick to complete and highly in demand.

Exploring these online degrees can provide flexible, cost-effective ways to enter or enhance your role in the growing healthcare sector.

Best Scientists Citing Jerry P. Palmer

Trending Scientists

Recently Published Articles